BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gui X, Liu S, Yan Y, Gao Z. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia. World J Gastroenterol 2013; 19(28): 4504-4510 [PMID: 23901225 DOI: 10.3748/wjg.v19.i28.4504] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Kasprzak A, Adamek A. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management. Int J Mol Sci 2020;21:E3494. [PMID: 32429087 DOI: 10.3390/ijms21103494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
2 Zygulska AL, Furgala A, Kaszuba-Zwoińska J, Krzemieniecki K, Gil K. Changes in plasma levels of cholecystokinin, neurotensin, VIP and PYY in gastric and colorectal cancer - Preliminary results. Peptides 2019;122:170148. [PMID: 31541684 DOI: 10.1016/j.peptides.2019.170148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
3 Nagarajan S, Alkayed NJ, Kaul S, Barnes AP. Effect of thermostable mutations on the neurotensin receptor 1 (NTSR 1 ) activation state. Journal of Biomolecular Structure and Dynamics 2020;38:340-53. [DOI: 10.1080/07391102.2019.1573705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Yarani R, Mirza AH, Kaur S, Pociot F. The emerging role of lncRNAs in inflammatory bowel disease. Exp Mol Med 2018;50:1-14. [PMID: 30523244 DOI: 10.1038/s12276-018-0188-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
5 Kamimae S, Yamamoto E, Kai M, Niinuma T, Yamano HO, Nojima M, Yoshikawa K, Kimura T, Takagi R, Harada E, Harada T, Maruyama R, Sasaki Y, Tokino T, Shinomura Y, Sugai T, Imai K, Suzuki H. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors. Oncotarget 2015;6:29975-90. [PMID: 26334593 DOI: 10.18632/oncotarget.5034] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
6 Massironi S, Zilli A, Cavalcoli F, Conte D, Peracchi M. Chromogranin A and other enteroendocrine markers in inflammatory bowel disease. Neuropeptides. 2016;58:127-134. [PMID: 26804239 DOI: 10.1016/j.npep.2016.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
7 Lopez-Dee ZP, Chittur SV, Patel H, Chinikaylo A, Lippert B, Patel B, Lawler J, Gutierrez LS. Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis. PLoS One 2015;10:e0139918. [PMID: 26461935 DOI: 10.1371/journal.pone.0139918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]